One week into her 1,000-kilometre trek of WA's Bibbulmun Track, 70-year-old Catherine Perversi says "the stillness is sublime ...

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

For investors, SRRK stock offers a high-probability FDA catalyst, meaningful upside in SMA, and additional optionality in obesity and more.

The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen's drug for a rare genetic ...

Internationally known stem cell expert who has led therapy development for late-stage cancers, immune disorders, motor neuron ...

Steve has found creative ways to fundraise for Motor Neurone Disease charities, from running the London Marathon to foraging ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in ...

In a poignant message shared online, actor Eric Dane has brought attention to the critical need for accelerated research into motor neuron disease (MND), also known as amyotrophic lateral sclerosis ...

The complete response letter was issued by the FDA during a routine inspection of a third-party fill-finish facility, not because of an issue with apitegromab.

Researchers at the University of Bath have discovered how DNA damage caused by a faulty DNA protection and repair system can lead to neurodegenerative ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a ...